Skip to content
MedsAcross

Medicine

Ycanth 3.2 mg/0.45 mL topical solution

Cantharidin · Topical · Verrica Pharmaceuticals
Available on requestPrescription onlyUS FDA

Ycanth 3.2 mg/0.45 mL topical solution is a prescription medicine containing Cantharidin for topical use, marketed by Verrica Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68° to 77°F), excursions permitted between 15°C to 30°C…

Key facts

Active ingredient (INN)
Cantharidin
Brand
Ycanth
Strength
3.2 mg/0.45 mL
Dosage form
Topical solution
Route
Topical
Packs
1 applicator, 6 package, 1 package and 1 more
Marketing authorisation holder
Verrica Pharmaceuticals
Manufacturer
Verrica Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68° to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F), protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
21 July 2023
Identifiers
RxCUI 244521, 2643442DailyMed set ID 7c9bdeaa-9822-4c69-a719-ea4a8643f59cNDC 71349-070, 71349-999Application NDA212905

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
1 applicator in 1 package / 1 ampule in 1 applicator / .45 mL in 1 ampule71349-070-01Verrica Pharmaceuticals21 July 2023
6 package in 1 carton / 1 applicator in 1 package / 1 ampule in 1 applicator / .45 mL in 1 ampule71349-070-06Verrica Pharmaceuticals21 July 2023
1 package in 1 carton / 1 applicator in 1 package / 1 ampule in 1 applicator / .45 mL in 1 ampule71349-070-11Verrica Pharmaceuticals21 July 2023
12 package in 1 carton / 1 applicator in 1 package / 1 ampule in 1 applicator / .45 mL in 1 ampule71349-070-12Verrica Pharmaceuticals21 July 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 July 2023Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Cantharidin is a prescription medicine indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older. It is available as topical solution. MedsAcross supplies Cantharidin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Cantharidin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Ycanth 3.2 mg/0.45 mL topical solution for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.